[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-01-23-1":3},{"date":4,"filings":5,"has_more":51,"limit":52,"page":53,"total_count":54},"2026-01-23",[6,14,18,26,33,37,44],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Strides Pharma Science Ltd","2026-01-23T21:39:26.533000","BSE","Upcoming Q3FY26 Earnings Call Scheduled for January 30, 2026","69739d91d413f5beed665cbf","STAR","• Strides Pharma has scheduled an earnings call to discuss Q3FY26 and nine months ended December 31, 2025 financial results\n• The call will feature Badree Komandur (Managing Director & Group CEO) and Vikesh Kumar (Group CFO)\n• Investors can join via pre-registration link or through dial-in numbers available for multiple countries (India, USA, Singapore, UK, Hong Kong)\n• Call scheduled for January 30, 2026 at 4:30 PM IST (11:00 AM GMT\u002F6:00 AM EST\u002F7:00 PM HKT)",{"company_name":7,"filing_date":8,"filing_source":9,"headline":15,"id":16,"stock_code":12,"summary_text":17},"Upcoming Q3FY26 Earnings Call Announcement","69739d910c576f69cb667d0a","• Strides Pharma has scheduled an earnings call on January 30, 2026, at 4:30 PM IST to discuss Q3FY26 financial results\n• Senior management participants include Badree Komandur (Managing Director & Group CEO) and Vikesh Kumar (Group CFO)\n• Investors can pre-register online or join via dial-in numbers available for multiple countries (India, USA, Singapore, UK, Hong Kong)",{"company_name":19,"filing_date":20,"filing_source":21,"headline":22,"id":23,"stock_code":24,"summary_text":25},"Bluspring Enterprises Limited","2026-01-23T15:39:29.575000","NSE","Board Meeting Scheduled for Q3 FY2025-26 Financial Results","697349fe8e61c963d6d09b26","BLUSPRING","• Board meeting scheduled for February 3, 2026 to consider and approve Q3 FY2025-26 unaudited financial results\n• Trading window closure in effect from January 1, 2026 to February 5, 2026\n• Both standalone and consolidated quarterly results will be reviewed",{"company_name":27,"filing_date":28,"filing_source":9,"headline":29,"id":30,"stock_code":31,"summary_text":32},"Kirloskar Pneumatic Company Ltd","2026-01-23T14:44:25.966000","Kirloskar Pneumatic Reports 18.7% YoY Growth in Q3 FY26 Profit with Strong Compression Systems Performance","69733c850c576f69cb66780c","KIRLPNU","• Revenue increased 18.7% YoY to ₹4,035 million in Q3 FY26 (vs ₹3,400 million in Q3 FY25)\n• Q3 FY26 profit before tax grew 26% YoY to ₹605 million (vs ₹480 million in Q3 FY25)\n• Compression Systems segment revenue rose 20.1% YoY to ₹3,792 million\n• Segment profit from Compression Systems increased 57.2% YoY to ₹943 million\n• Board declared interim dividend of 175% (₹3.50 per equity share)\n• Company recorded exceptional expense of ₹183 million due to new labor codes impact",{"company_name":27,"filing_date":28,"filing_source":9,"headline":34,"id":35,"stock_code":31,"summary_text":36},"Kirloskar Pneumatic Reports 26% YoY Growth in Q3 FY26 Profit with Strong Compression Systems Performance","69733c87eef3895f5b9dee2a","• Revenue increased 18.7% YoY to ₹4,035M in Q3 FY26 (vs ₹3,400M in Q3 FY25) and 6.7% QoQ\n• Q3 FY26 profit before tax grew to ₹605M, up 26% YoY despite ₹183M exceptional expense from new labor codes\n• Compression Systems segment revenue rose 20.1% YoY to ₹3,792M, with segment profit increasing 57.2% YoY to ₹943M\n• Board declared interim dividend of 175% (₹3.50 per share)\n• Company maintains strong capital position with total capital employed of ₹11,782M",{"company_name":38,"filing_date":39,"filing_source":21,"headline":40,"id":41,"stock_code":42,"summary_text":43},"The Motor & General Finance Limited","2026-01-23T14:39:28.404000","Board Meeting Scheduled for Q3 FY2025-26 Financial Results Review","69733b1d199dcd549585d0b5","MOTOGENFIN","• Board meeting scheduled for February 12, 2026 to consider Q3 FY2025-26 unaudited financial results (both standalone and consolidated)\n• Trading window closure in effect from January 1, 2026 through February 14, 2026 for designated persons\n• Results for the quarter ending December 2025 will be reviewed during this meeting",{"company_name":45,"filing_date":46,"filing_source":9,"headline":47,"id":48,"stock_code":49,"summary_text":50},"Ladderup Finance Ltd","2026-01-23T11:39:25.816000","Board Meeting Scheduled for Q3 FY2026 Financial Results","697310af1e9e72baba85ae3a","530577","• Board meeting to be held on Friday, January 30, 2026, to consider and approve unaudited financial results (Standalone and Consolidated) for Q3 and nine months ended December 31, 2025\n• Trading window for company securities currently closed; will reopen 48 hours after declaration of financial results\n• Meeting notification issued in compliance with Regulation 29 of SEBI Listing Obligations and Disclosure Requirements",false,100,1,7]